ReCor Medical, Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   US GPS · Global Paradise System US Post Approval Study

   Primary completion pushed from Sep 2026 to Dec 2028

   Also in this update: Trial sites expanded: 43 → 46 locations

   ReCor Medical, Inc.·Not specified· NCT06297291· Registry history of NCT06297291 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   RADIANCE-II · RADIANCE II Pivotal Study: A Study of the ReCor…RADIANCE-II · RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

   Primary endpoint(s) modified

   Also in this update: Results posted: Sep 24, 2026; Study completion pushed from Jul 2027 to Jul 2029

   ReCor Medical, Inc.·Not applicable· NCT03614260· Registry history of NCT03614260 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.